CIM
TGTX icon

CIM Investment Management’s TG Therapeutics TGTX Stock Holding History

CIM Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,915
Closed -$214K – 252
2025
Q3 		$214K Sell
5,915
-105
-2% -$3.46K 0.06% 222
2025
Q2 		$217K Sell
6,020
-100
-2% -$3.72K 0.04% 234
2025
Q1 		$241K Buy
+6,120
New +$206K 0.06% 201
2023
Q2 		– Sell
-15,521
Closed -$233K – 293
2023
Q1 		$233K Buy
15,521
+535
+4% +$8.13K 0.09% 224
2022
Q4 		$177K Hold
14,986
– – 0.07% 229
2022
Q3 		$89K Hold
14,986
– – 0.04% 214
2022
Q2 		$64K Hold
14,986
– – 0.03% 228
2022
Q1 		$143K Buy
+14,986
New +$173K 0.05% 242
2021
Q4 		– Sell
-6,214
Closed -$207K – 315
2021
Q3 		$207K Hold
6,214
– – 0.07% 284
2021
Q2 		$241K Buy
+6,214
New +$244K 0.07% 254

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

CIM Investment Management's TGTX Position: Q4 2025 in Review

CIM Investment Management sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 5,915 shares — an estimated $214K sold.

CIM Investment Management first reported a position in TGTX in Q2 2021 and held it in 10 quarters. The position peaked at $241K in Q1 2025. 352 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • CIM Investment Management reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • CIM Investment Management sold 5,915 TG Therapeutics shares in Q4 2025, an estimated $214K.
  • CIM Investment Management first reported a position in TG Therapeutics in Q2 2021 and held it in 10 quarters.
  • CIM Investment Management's TG Therapeutics position peaked at $241K in Q1 2025.
  • 352 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on CIM Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.